ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 117 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 2.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $10,163,000 | -43.5% | 143,481 | -31.8% | 1.28% | -54.1% |
Q3 2018 | $17,981,000 | -35.2% | 210,400 | -74.6% | 2.80% | -50.8% |
Q4 2016 | $27,746,000 | +32.0% | 828,253 | +4.8% | 5.70% | +6.3% |
Q3 2016 | $21,022,000 | +77.2% | 790,000 | +46.8% | 5.36% | +57.8% |
Q2 2016 | $11,863,000 | +653.2% | 538,024 | +1437.2% | 3.40% | +453.3% |
Q2 2015 | $1,575,000 | -48.6% | 35,000 | -65.0% | 0.61% | -54.5% |
Q1 2015 | $3,062,000 | – | 100,000 | – | 1.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |